Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.

Agarwal, Roshan; Alifrangis, Costi; Everard, Janet; Savage, Philip M; Short, Dee; Tidy, John; Fisher, Rosemary A; Sebire, Neil J; Harvey, Richard; Hancock, Barry W; Coleman, Robert E; Seckl, Michael J

Agarwal, Roshan; Alifrangis, Costi; Everard, Janet; Savage, Philip M; Short, Dee; Tidy, John; Fisher, Rosemary A; Sebire, Neil J; Harvey, Richard; Hancock, Barry W; Coleman, Robert E; Seckl, Michael J.

Afiliação

Agarwal R; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Alifrangis C; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Everard J; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Savage PM; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Short D; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Tidy J; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Fisher RA; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Sebire NJ; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Harvey R; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Hancock BW; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Coleman RE; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.
Seckl MJ; Charing Cross Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Academic Science NHS Trust, UK.

J Reprod Med ; 59(1-2): 7-12, 2014.

Article em En | MEDLINE | ID: mdl-24597279

Assuntos

Doença Trofoblástica Gestacional/tratamento farmacológico; Doença Trofoblástica Gestacional/mortalidade; Adulto; Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Gonadotropina Coriônica/sangue; Ciclofosfamida/administração & dosagem; Ciclofosfamida/uso terapêutico; Dactinomicina/administração & dosagem; Dactinomicina/uso terapêutico; Resistencia a Medicamentos Antineoplásicos; Etoposídeo/administração & dosagem; Etoposídeo/uso terapêutico; Feminino; Doença Trofoblástica Gestacional/patologia; Hospitais Especializados; Humanos; Metotrexato/administração & dosagem; Metotrexato/uso terapêutico; Recidiva Local de Neoplasia; Estadiamento de Neoplasias; Gravidez; Prognóstico; Fatores de Risco; Taxa de Sobrevida; Resultado do Tratamento; Reino Unido; Vincristina/administração & dosagem; Vincristina/uso terapêutico

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Trofoblástica Gestacional Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: J Reprod Med Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido

Buscar no Google

Imprimir

XML

PubMed Links